Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial

BACKGROUND: Heart disease is an important cause of morbidity and mortality in cats, but there is limited evidence of the benefit of any medication. HYPOTHESIS: The angiotensin‐converting enzyme inhibitor benazepril would delay the time to treatment failure in cats with heart disease of various etiol...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Jonathan N., Martin, Mike, Chetboul, Valérie, Ferasin, Luca, French, Anne T., Strehlau, Günther, Seewald, Wolfgang, Smith, Sarah G. W., Swift, Simon T., Roberts, Susan L., Harvey, Andrea M., Little, Christopher J. L., Caney, Sarah M. A., Simpson, Kerry E., Sparkes, Andrew H., Mardell, Eleanor J., Bomassi, Eric, Muller, Claude, Sauvage, John P., Diquélou, Armelle, Schneider, Matthias A., Brown, Laurence J., Clarke, David D., Rousselot, Jean‐Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872620/
https://www.ncbi.nlm.nih.gov/pubmed/31560137
http://dx.doi.org/10.1111/jvim.15572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872620/
https://www.ncbi.nlm.nih.gov/pubmed/31560137
http://dx.doi.org/10.1111/jvim.15572

Ejemplares similares